Samuel N. Markowitz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Samuel N. Markowitz has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Monica Daibert-Nido
Department of Ophthalmology and Vision Sciences, Toronto Western Hospital, University Health Network, 399 Bathurst St., Toronto, ON M5T 2S8, Canada
10 shared publications Michelle Markowitz
Private Practice, Toronto, ON, Canada
7 shared publications- Ghaliah Nsour
Department of Ophthalmology and Vision Sciences, Toronto Western Hospital, University Health Network, 399 Bathurst St., Toronto, ON M5T 2S8, Canada
4 shared publications - Mariana Akemi Matsura Misawa
Department of Ophthalmology and Vision Sciences, Toronto Western Hospital, University Health Network, 399 Bathurst St., Toronto, ON M5T 2S8, Canada
4 shared publications Yulia Pyatova
Low Vision Service, (University Health Network Hospitals), Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada
3 shared publications- Aljeena Rahat Qureshi
Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
2 shared publications
Latest Publications
- Open Access
- 10 October 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (10) , 1089
Short- and Long-Term Outcomes After MAIA-Guided Biofeedback Training in 346 Patients with Low Vision: A Retrospective Cohort Study
Purpose: To describe short- and long-term visual outcomes after MAIA microperimetry biofeedback training (BT) in a low-vision rehabilitation cohort. Methods: Retrospective study of patients who completed BT between 2017 and 2023 (4.1 ± 0.6 sessions). The MAIA device recorded P1 and P2 parameters, defined as the percentage of fundus-tracked fixation points falling within device-defined circular windows centered on the trained retinal locus (TRL). Outcomes: baseline, short-term follow-up (<6 months), and long-term follow-up (≥6 months): P1, P2, best-corrected distance visual acuity (BCVA), near visual acuity, fixation stability (BCEA), mean retinal sensitivity (dB), and reading speed (wpm) MNRead app. Results: A total of 346 participants were included. Median P1 increased from 21.5% at Session 1 to 32.0% at Session 5, and P2 increased from 66.0% to 81.5%. Distance and near visual acuity improved significantly at short-term follow-up but were not significantly different from baseline in the overall cohort at long-term follow-up. Reading speed, BCEA, and mean retinal sensitivity did not show significant longitudinal changes. In an exploratory secondary analysis excluding eyes with worsening BCVA, distance and near visual acuity remained significantly improved at long-term follow-up. Conclusions: MAIA-guided BT was associated with improved within-training fixation performance and short-term visual acuity in this heterogeneous retrospective cohort. Long-term improvement was not demonstrated in the overall cohort; exploratory analyses suggest that underlying disease progression may influence long-term outcomes. Prospective controlled studies are required to determine durability and efficacy.
- 10 October 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (10) , 1089
Open AccessShort- and Long-Term Outcomes After MAIA-Guided Biofeedback Training in 346 Patients with Low Vision: A Retrospective Cohort Study
Purpose: To describe short- and long-term visual outcomes after MAIA microperimetry biofeedback training (BT) in a low-vision rehabilitation cohort. Methods: Retrospective study of patients who completed BT between 2017 and 2023 (4.1 ± 0.6 sessions). The MAIA device recorded P1 and P2 parameters, defined as the percentage of fundus-tracked fixation points falling within device-defined circular windows centered on the trained retinal locus (TRL). Outcomes: baseline, short-term follow-up (<6 months), and long-term follow-up (≥6 months): P1, P2, best-corrected distance visual acuity (BCVA), near visual acuity, fixation stability (BCEA), mean retinal sensitivity (dB), and reading speed (wpm) MNRead app. Results: A total of 346 participants were included. Median P1 increased from 21.5% at Session 1 to 32.0% at Session 5, and P2 increased from 66.0% to 81.5%. Distance and near visual acuity improved significantly at short-term follow-up but were not significantly different from baseline in the overall cohort at long-term follow-up. Reading speed, BCEA, and mean retinal sensitivity did not show significant longitudinal changes. In an exploratory secondary analysis excluding eyes with worsening BCVA, distance and near visual acuity remained significantly improved at long-term follow-up. Conclusions: MAIA-guided BT was associated with improved within-training fixation performance and short-term visual acuity in this heterogeneous retrospective cohort. Long-term improvement was not demonstrated in the overall cohort; exploratory analyses suggest that underlying disease progression may influence long-term outcomes. Prospective controlled studies are required to determine durability and efficacy.
- Open Access
- 19 August 2026
- Published by MDPI AG in Preprints.org
Short- and Long-Term Outcomes After MAIA-Guided Biofeedback Training in 346 Patients with Low Vision: A Retrospective Cohort Study
Purpose: To describe short- and long-term visual outcomes after MAIA microperimetry Biofeedback Training (BT) in a low-vision rehabilitation cohort. Methods: Retrospective study of patients who completed BT between 2017 and 2023 (4.1 ± 0.6 sessions). The MAIA device recorded P1 and P2 parameters, defined as the percentage of fundus-tracked fixation points falling within device-defined circular windows centered on the trained retinal locus (TRL). Outcomes: baseline, short-term follow-up (< 6 months), and long-term follow-up (≥6 months): best-corrected distance visual acuity (BCVA), near visual acuity, fixation stability (BCEA), mean retinal sensitivity (dB), and reading speed (wpm) MNRead app. Results: 346 participants studied. Performance increased: median P1 from 21.5% in session 1 to 32% in session 5, P2 from 66% in session 1 to 81.5% in Session 5. BCVA increased from baseline to short-term follow-up (median 0.40 to 0.30 logMAR; F(2,797)=14.04, p< 0.0001), long-term follow-up did not. Near vision had an improvement (F(2,770)=8.54, p< 0.0001) but no long-term difference from baseline (p=0.0563). In a secondary analysis excluding eyes with documented disease progression, improvements in both distance and near vision were sustained at the long-term follow-up. This finding suggests that disease progression likely attenuated the long-term effect in the full cohort. Conclusions: BT led to significant short-and- long term functional gains in the absence of disease progression. Given the retrospective design, these findings remain hypothesis-generating evidence supporting further studies.
- 19 August 2026
- Published by MDPI AG in Preprints.org
Open AccessShort- and Long-Term Outcomes After MAIA-Guided Biofeedback Training in 346 Patients with Low Vision: A Retrospective Cohort Study
Purpose: To describe short- and long-term visual outcomes after MAIA microperimetry Biofeedback Training (BT) in a low-vision rehabilitation cohort. Methods: Retrospective study of patients who completed BT between 2017 and 2023 (4.1 ± 0.6 sessions). The MAIA device recorded P1 and P2 parameters, defined as the percentage of fundus-tracked fixation points falling within device-defined circular windows centered on the trained retinal locus (TRL). Outcomes: baseline, short-term follow-up (< 6 months), and long-term follow-up (≥6 months): best-corrected distance visual acuity (BCVA), near visual acuity, fixation stability (BCEA), mean retinal sensitivity (dB), and reading speed (wpm) MNRead app. Results: 346 participants studied. Performance increased: median P1 from 21.5% in session 1 to 32% in session 5, P2 from 66% in session 1 to 81.5% in Session 5. BCVA increased from baseline to short-term follow-up (median 0.40 to 0.30 logMAR; F(2,797)=14.04, p< 0.0001), long-term follow-up did not. Near vision had an improvement (F(2,770)=8.54, p< 0.0001) but no long-term difference from baseline (p=0.0563). In a secondary analysis excluding eyes with documented disease progression, improvements in both distance and near vision were sustained at the long-term follow-up. This finding suggests that disease progression likely attenuated the long-term effect in the full cohort. Conclusions: BT led to significant short-and- long term functional gains in the absence of disease progression. Given the retrospective design, these findings remain hypothesis-generating evidence supporting further studies.
- Open Access
- 3 August 2026
- Published by JMIR Publications Inc. in JMIR Rehabilitation and Assistive Technologies
- Vol. 13, e87596
A Visual Telerehabilitation Program in Virtual Reality for Age-Related Macular Degeneration: Randomized Feasibility and Proof-of-Concept Trial
Background: Age-related macular degeneration (AMD) causes progressive central vision loss in older adults. Low-vision rehabilitation can improve functional vision by training the use of a preferred retinal locus, commonly through clinic-based biofeedback training (BFT). However, repeated supervised rehabilitation is burdensome, and functional gains may be difficult to sustain without home practice. Stand-alone virtual reality (VR) may enable home-based, remotely monitored visual stimulation, but feasibility, safety, and usability in older adults with AMD remain insufficiently characterized. Objective: This study aimed to evaluate the feasibility and safety of adding home-based VR 3D single-object tracking (3D-SOT-VR) to conventional BFT in older adults with dry AMD in a parallel, randomized, single-blind (to assessors), controlled, formative trial and to generate exploratory functional hypotheses for a future trial. Methods: Adults with dry AMD were recruited at the Low Vision Clinic, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada, from September 2021 to October 2023. Participants were randomized to BFT once weekly for 4 weeks (BFT group) or BFT plus home-based 3D-SOT-VR (BFT-VR group) every other day for 4 weeks. Experimental intervention consisted of tracking a single object among distractors moving at different speeds in a 3D virtual space in a VR headset. Primary feasibility and safety outcomes included recruitment, adoption, adherence, compliance, intervention completion, remote data transfer, usability, and VR-induced symptoms and effects. Secondary outcomes included visual acuity, contrast sensitivity, fixation stability, retinal sensitivity, reading speed, and low-vision quality of life. Exploratory outcomes assessed performance at 3D-SOT-VR and usage. Analyses were descriptive and exploratory, with CIs and denominators reported to reflect limited precision and missingness. Results: Fourteen individuals were randomized (BFT, n=6; BFT-VR, n=8), below the planned sample size of 32. Recruitment was not achieved because of COVID-19–related interruptions and reduced onsite access. Eleven individuals were analyzed for the primary outcome (BFT n=6, BFT-VR n=5). Intervention completion was 100% in the BFT arm and 75% in the BFT-VR arm, below the prespecified BFT-VR threshold. Among participants who used VR, adherence to scheduled home sessions was acceptable, completed VR-session files were transmitted without loss, and no participant met the predefined cybersickness stopping rule. One BFT-VR participant discontinued because headset weight caused neck fatigue. Group-level visual outcomes did not provide significant effectiveness. Reading speed showed a clinically meaningful individual-level improvement in the BFT-VR arm and correlated with VR-task performance. The findings were not clearly durable at follow-up. Conclusions: This pilot study provides formative evidence that clinic-based BFT combined with home-based, remotely monitored VR visual stimulation can be implemented safely in older adults with dry AMD, while identifying major contextual feasibility barriers. The intervention is innovative because it extends low-vision rehabilitation into the home using a connected device and objective performance monitoring. Recruitment, retention, missing data handling, and sustainability of functional gains must be addressed before effectiveness testing.
- 3 August 2026
- Published by JMIR Publications Inc. in JMIR Rehabilitation and Assistive Technologies
- Vol. 13, e87596
Open AccessA Visual Telerehabilitation Program in Virtual Reality for Age-Related Macular Degeneration: Randomized Feasibility and Proof-of-Concept Trial
Background: Age-related macular degeneration (AMD) causes progressive central vision loss in older adults. Low-vision rehabilitation can improve functional vision by training the use of a preferred retinal locus, commonly through clinic-based biofeedback training (BFT). However, repeated supervised rehabilitation is burdensome, and functional gains may be difficult to sustain without home practice. Stand-alone virtual reality (VR) may enable home-based, remotely monitored visual stimulation, but feasibility, safety, and usability in older adults with AMD remain insufficiently characterized. Objective: This study aimed to evaluate the feasibility and safety of adding home-based VR 3D single-object tracking (3D-SOT-VR) to conventional BFT in older adults with dry AMD in a parallel, randomized, single-blind (to assessors), controlled, formative trial and to generate exploratory functional hypotheses for a future trial. Methods: Adults with dry AMD were recruited at the Low Vision Clinic, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada, from September 2021 to October 2023. Participants were randomized to BFT once weekly for 4 weeks (BFT group) or BFT plus home-based 3D-SOT-VR (BFT-VR group) every other day for 4 weeks. Experimental intervention consisted of tracking a single object among distractors moving at different speeds in a 3D virtual space in a VR headset. Primary feasibility and safety outcomes included recruitment, adoption, adherence, compliance, intervention completion, remote data transfer, usability, and VR-induced symptoms and effects. Secondary outcomes included visual acuity, contrast sensitivity, fixation stability, retinal sensitivity, reading speed, and low-vision quality of life. Exploratory outcomes assessed performance at 3D-SOT-VR and usage. Analyses were descriptive and exploratory, with CIs and denominators reported to reflect limited precision and missingness. Results: Fourteen individuals were randomized (BFT, n=6; BFT-VR, n=8), below the planned sample size of 32. Recruitment was not achieved because of COVID-19–related interruptions and reduced onsite access. Eleven individuals were analyzed for the primary outcome (BFT n=6, BFT-VR n=5). Intervention completion was 100% in the BFT arm and 75% in the BFT-VR arm, below the prespecified BFT-VR threshold. Among participants who used VR, adherence to scheduled home sessions was acceptable, completed VR-session files were transmitted without loss, and no participant met the predefined cybersickness stopping rule. One BFT-VR participant discontinued because headset weight caused neck fatigue. Group-level visual outcomes did not provide significant effectiveness. Reading speed showed a clinically meaningful individual-level improvement in the BFT-VR arm and correlated with VR-task performance. The findings were not clearly durable at follow-up. Conclusions: This pilot study provides formative evidence that clinic-based BFT combined with home-based, remotely monitored VR visual stimulation can be implemented safely in older adults with dry AMD, while identifying major contextual feasibility barriers. The intervention is innovative because it extends low-vision rehabilitation into the home using a connected device and objective performance monitoring. Recruitment, retention, missing data handling, and sustainability of functional gains must be addressed before effectiveness testing.
- Open Access
- 20 July 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (7) , 759
Abnormal Ipsilesional Hemifields and Improvement Post-Biofeedback Training in Patients with Hemianopia Measured with the MAIA Microperimeter
Introduction: This study analyzes the ipsilesional hemifields in patients with hemianopia and biofeedback training (BT). Methods: Prospectively, BT stimulated the paracentral ipsilesional hemifields. BT was compared to a control group using C 10-2 program 68 points on the MAIA microperimetry (Centervue, Padova, Italy). Five weekly BT sessions of 20 min were delivered. A total of 34 subjects enrolled, with 28 in treatment, and six in control group. Outcomes: General retinal sensitivity (RS), average of the central two columns, the paracentral column of the blind hemifield, ipsilesional hemifield, and the whole ipsilesional and blind hemifields. Paired t-tests were used for statistical analysis. Results: Control and treatment groups were equal demographically. In the control group, no difference was found pre-and-post BT. Baseline RS on the ipsilesional hemifield was 21.4 ± 4.5, lower than the normal cut-off value of 25 dB (p < 0.001). BT improved RS from 14.0 ± 4.2 to 15.0 ± 4.8, p = 0.01, paracentral two columns, 16.3 ± 5.3 to 17.8 ± 5.6, p = 0.01, central column in ipsilesional hemifield, 20.7 ± 5.4 to 21.8 ± 4.8, p = 0.05, and ipsilesional hemifield, 21.42 ± 4.8 to 22.39 ± 4.24), p = 0.01. Conclusions: Ipsilesional hemifields were abnormal and BT improved RS, benefiting patients with hemianopia.
- 20 July 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (7) , 759
Open AccessAbnormal Ipsilesional Hemifields and Improvement Post-Biofeedback Training in Patients with Hemianopia Measured with the MAIA Microperimeter
Introduction: This study analyzes the ipsilesional hemifields in patients with hemianopia and biofeedback training (BT). Methods: Prospectively, BT stimulated the paracentral ipsilesional hemifields. BT was compared to a control group using C 10-2 program 68 points on the MAIA microperimetry (Centervue, Padova, Italy). Five weekly BT sessions of 20 min were delivered. A total of 34 subjects enrolled, with 28 in treatment, and six in control group. Outcomes: General retinal sensitivity (RS), average of the central two columns, the paracentral column of the blind hemifield, ipsilesional hemifield, and the whole ipsilesional and blind hemifields. Paired t-tests were used for statistical analysis. Results: Control and treatment groups were equal demographically. In the control group, no difference was found pre-and-post BT. Baseline RS on the ipsilesional hemifield was 21.4 ± 4.5, lower than the normal cut-off value of 25 dB (p < 0.001). BT improved RS from 14.0 ± 4.2 to 15.0 ± 4.8, p = 0.01, paracentral two columns, 16.3 ± 5.3 to 17.8 ± 5.6, p = 0.01, central column in ipsilesional hemifield, 20.7 ± 5.4 to 21.8 ± 4.8, p = 0.05, and ipsilesional hemifield, 21.42 ± 4.8 to 22.39 ± 4.24), p = 0.01. Conclusions: Ipsilesional hemifields were abnormal and BT improved RS, benefiting patients with hemianopia.
- Open Access
- 5 June 2026
- Published by MDPI AG in Preprints.org
Abnormal Ipsilesional Hemifields and Improvement Post- Biofeedback Training in Patients with Hemianopia Measured with the MAIA Microperimeter
Introduction - This study analyzes the ipsilesional hemifields in patients with hemianopia and Biofeedback Training (BT). Methods - Prospectively, BT stimulated the paracentral ipsilesional hemifields. BT was compared to a control group using C 10-2 program 68 points on the MAIA microperimetry (Centervue, Padova, Italy). Five weekly BT sessions of 20 minutes delivered. 34 subjects enrolled, 28 in treatment, 6 into control group. Outcomes: General retinal sensitivity (RS), average of the central two columns, the paracentral column of the blind hemifield, ipsilesional hemifield, and the whole ipsilesional and blind hemifields. Paired t-tests used for statistical analysis. Results - Control and treatment groups were equal demographically. In control group, no difference found pre-and-post BT. Baseline RS on the ipsilesional hemifield was 21.4 ± 4.5, lower than the normal cut-off value of 25 dB (p < 0.001). BT improved RS from 14.0 ± 4.2 (1.6, 20.9) to 15.0 ± 4.8 (3.8, 27.5), p= 0.01, paracentral two columns, 16.3 ± 5.3 (2.2, 24.5) to 17.8 ± 5.6 (3.8, 30.7), p = 0.01, central column in ipsilesional hemifield, 20.7 ± 5.4 (2.2, 29.1) to 21.8 ± 4.8 (7.3, 30.7), p = 0.05, and ipsilesional hemifield, 21.42 ± 4.8 (2.5, 28.5) to 22.39 ± 4.24 (7.5, 29.4), p=0.01.Discussion - Ipsilesional hemifields were abnormal and BT improved RS, benefiting patients with hemianopia.
- 5 June 2026
- Published by MDPI AG in Preprints.org
Open AccessAbnormal Ipsilesional Hemifields and Improvement Post- Biofeedback Training in Patients with Hemianopia Measured with the MAIA Microperimeter
Introduction - This study analyzes the ipsilesional hemifields in patients with hemianopia and Biofeedback Training (BT). Methods - Prospectively, BT stimulated the paracentral ipsilesional hemifields. BT was compared to a control group using C 10-2 program 68 points on the MAIA microperimetry (Centervue, Padova, Italy). Five weekly BT sessions of 20 minutes delivered. 34 subjects enrolled, 28 in treatment, 6 into control group. Outcomes: General retinal sensitivity (RS), average of the central two columns, the paracentral column of the blind hemifield, ipsilesional hemifield, and the whole ipsilesional and blind hemifields. Paired t-tests used for statistical analysis. Results - Control and treatment groups were equal demographically. In control group, no difference found pre-and-post BT. Baseline RS on the ipsilesional hemifield was 21.4 ± 4.5, lower than the normal cut-off value of 25 dB (p < 0.001). BT improved RS from 14.0 ± 4.2 (1.6, 20.9) to 15.0 ± 4.8 (3.8, 27.5), p= 0.01, paracentral two columns, 16.3 ± 5.3 (2.2, 24.5) to 17.8 ± 5.6 (3.8, 30.7), p = 0.01, central column in ipsilesional hemifield, 20.7 ± 5.4 (2.2, 29.1) to 21.8 ± 4.8 (7.3, 30.7), p = 0.05, and ipsilesional hemifield, 21.42 ± 4.8 (2.5, 28.5) to 22.39 ± 4.24 (7.5, 29.4), p=0.01.Discussion - Ipsilesional hemifields were abnormal and BT improved RS, benefiting patients with hemianopia.
- Open Access
- 11 November 2025
- Published by JMIR Publications Inc. in JMIR Preprints
A visual telerehabilitation program in virtual reality in age-related macular degeneration: a randomized feasibility and proof-of-concept trial. (Preprint)
BACKGROUND Age-related macular degeneration (AMD), characterized by central vision loss, is the leading cause of visual impairment worldwide. Contemporary rehabilitation approaches, including biofeedback training (BFT), improve visual function and quality of life by optimizing use of a healthier or “preferred” retinal locus (PRL) identified by the clinician. BFT is typically delivered weekly or bi-weekly for several weeks in clinical settings under supervision of an eye-care professional. Nevertheless, after clinic-based programs, patients often revert to suboptimal PRLs, worsening disability. Sustaining use of the trained PRL likely requires daily visual rehabilitation. However, such regimens increase treatment burden. Standalone, remotely controlled virtual reality (VR) platforms could offer a practical alternative for at-home daily training. OBJECTIVE The primary objective of this pilot study was to evaluate feasibility (acceptability, adherence, usability remote data collection and safety) of a home-based VR visual rehabilitation program for older adults with dry AMD. Secondary objectives investigated the effect of the visual telerehabilitation program on visual function and functional vision. Exploratory outcomes addressed performance at the VR program. METHODS This study explored combining BFT with 3D single object-tracking in VR (3D-SOT-VR) to enhance visual perception and quality of life in AMD patients. The 4-week, two-arm pilot trial involved 14 patients with dry AMD, randomized to either BFT or BFT-VR groups. The BFT group had weekly sessions of BFT, while the BFT-VR group also engaged in 3D-SOT-VR stimulation at home every other day for 4 weeks. Secondary outcome measures were taken at baseline, after intervention at 4 weeks and at 1-month and 6-month follow-up. RESULTS Feasibility criteria were hampered by low recruitment rates due to the COVID-19 pandemic. The study indicates adoption of the VR technology in older adults with no significant adverse events. Data was collected remotely without any loss. Visual outcomes showed clinically meaningful gains at the individual level in reading speed for the combination of BFT with 3D-SOT-VR. Reading speed improvement was directly correlated to the performance at the 3D-SOT-VR stimulation, emphasizing the beneficial effect of single object tracking on reading abilities. CONCLUSIONS Virtual reality represents a tool that can be safely implemented as supportive care in older adults. Further research is required with adapted VR ergonomics for older adults to address effectiveness and long-term benefits of home-based VR interventions for AMD patients. CLINICALTRIAL clinicaltrials.gov, NCT04685824 posted 28/12/2020.
- 11 November 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA visual telerehabilitation program in virtual reality in age-related macular degeneration: a randomized feasibility and proof-of-concept trial. (Preprint)
BACKGROUND Age-related macular degeneration (AMD), characterized by central vision loss, is the leading cause of visual impairment worldwide. Contemporary rehabilitation approaches, including biofeedback training (BFT), improve visual function and quality of life by optimizing use of a healthier or “preferred” retinal locus (PRL) identified by the clinician. BFT is typically delivered weekly or bi-weekly for several weeks in clinical settings under supervision of an eye-care professional. Nevertheless, after clinic-based programs, patients often revert to suboptimal PRLs, worsening disability. Sustaining use of the trained PRL likely requires daily visual rehabilitation. However, such regimens increase treatment burden. Standalone, remotely controlled virtual reality (VR) platforms could offer a practical alternative for at-home daily training. OBJECTIVE The primary objective of this pilot study was to evaluate feasibility (acceptability, adherence, usability remote data collection and safety) of a home-based VR visual rehabilitation program for older adults with dry AMD. Secondary objectives investigated the effect of the visual telerehabilitation program on visual function and functional vision. Exploratory outcomes addressed performance at the VR program. METHODS This study explored combining BFT with 3D single object-tracking in VR (3D-SOT-VR) to enhance visual perception and quality of life in AMD patients. The 4-week, two-arm pilot trial involved 14 patients with dry AMD, randomized to either BFT or BFT-VR groups. The BFT group had weekly sessions of BFT, while the BFT-VR group also engaged in 3D-SOT-VR stimulation at home every other day for 4 weeks. Secondary outcome measures were taken at baseline, after intervention at 4 weeks and at 1-month and 6-month follow-up. RESULTS Feasibility criteria were hampered by low recruitment rates due to the COVID-19 pandemic. The study indicates adoption of the VR technology in older adults with no significant adverse events. Data was collected remotely without any loss. Visual outcomes showed clinically meaningful gains at the individual level in reading speed for the combination of BFT with 3D-SOT-VR. Reading speed improvement was directly correlated to the performance at the 3D-SOT-VR stimulation, emphasizing the beneficial effect of single object tracking on reading abilities. CONCLUSIONS Virtual reality represents a tool that can be safely implemented as supportive care in older adults. Further research is required with adapted VR ergonomics for older adults to address effectiveness and long-term benefits of home-based VR interventions for AMD patients. CLINICALTRIAL clinicaltrials.gov, NCT04685824 posted 28/12/2020.
- Open Access
- 26 January 2021
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 31 (6) , 3324-3331
Post audio-visual biofeedback training visual functions and quality of life in paediatric idiopathic infantile nystagmus: A pilot study
Biofeedback training (BT) was adapted to idiopathic infantile nystagmus syndrome (IINS) cases to enhance visual functions and quality of life (QoL). 10 patients (age 9 ± 3.2 years) treated with the audio-visual BT module of the MAIA microperimeter (Centervue, Padova, Italy) were assessed in two baseline visits and 1week post-BT (BT 80 min in total). The outcomes were distance and near binocular best corrected visual acuity (BBCVA), fixation stability, reading speed, contrast sensitivity, stereopsis and Children’s Visual Function Questionnaire. One-way repeated measured ANOVA and paired t-tests were used. Distance BBCVA improved from 0.46 ± 0.21 and 0.43 ± 0.18 pre-BT to 0.33 ± 0.2 logMAR post-BT (F (2,27) = 13.75, p = 0.0002). Post-BT was better than baseline (p = 0.0001) and pre-BT (p = 0.001). Near BBCVA improved from 0.23 ± 0.09 and 0.21 ± 0.14 pre-BT to 0.04 ± 0.08 post-BT (F (2,27) = 22.12, p = 0.000014), post-BT was better than baseline (p = 0.0001) and pre-BT (p = 0.0006). Stereopsis improved from 283 ± 338″ to 39 ± 32.2″ (p = 0.04), contrast sensitivity from 0.26 ± 0.17 to 0.08 ± 0.12 log units (p = 0.01), and reading speed improved from 74.7 ± 51.2 wpm to 104.7 ± 53.6 wpm (p = 0.0006). Fixation stability improved from 33.6 ± 28.1 to 14.3 ± 10.1 sq. QoL increased from 23.8 ± 2.2 to 26.3 ± 2.3 units (p = 0.001). BT benefited all visual functions and QoL in this pilot study, heralding a new possibility for Low Vision Rehabilitation in IINS.
- 26 January 2021
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 31 (6) , 3324-3331
Open AccessPost audio-visual biofeedback training visual functions and quality of life in paediatric idiopathic infantile nystagmus: A pilot study
Biofeedback training (BT) was adapted to idiopathic infantile nystagmus syndrome (IINS) cases to enhance visual functions and quality of life (QoL). 10 patients (age 9 ± 3.2 years) treated with the audio-visual BT module of the MAIA microperimeter (Centervue, Padova, Italy) were assessed in two baseline visits and 1week post-BT (BT 80 min in total). The outcomes were distance and near binocular best corrected visual acuity (BBCVA), fixation stability, reading speed, contrast sensitivity, stereopsis and Children’s Visual Function Questionnaire. One-way repeated measured ANOVA and paired t-tests were used. Distance BBCVA improved from 0.46 ± 0.21 and 0.43 ± 0.18 pre-BT to 0.33 ± 0.2 logMAR post-BT (F (2,27) = 13.75, p = 0.0002). Post-BT was better than baseline (p = 0.0001) and pre-BT (p = 0.001). Near BBCVA improved from 0.23 ± 0.09 and 0.21 ± 0.14 pre-BT to 0.04 ± 0.08 post-BT (F (2,27) = 22.12, p = 0.000014), post-BT was better than baseline (p = 0.0001) and pre-BT (p = 0.0006). Stereopsis improved from 283 ± 338″ to 39 ± 32.2″ (p = 0.04), contrast sensitivity from 0.26 ± 0.17 to 0.08 ± 0.12 log units (p = 0.01), and reading speed improved from 74.7 ± 51.2 wpm to 104.7 ± 53.6 wpm (p = 0.0006). Fixation stability improved from 33.6 ± 28.1 to 14.3 ± 10.1 sq. QoL increased from 23.8 ± 2.2 to 26.3 ± 2.3 units (p = 0.001). BT benefited all visual functions and QoL in this pilot study, heralding a new possibility for Low Vision Rehabilitation in IINS.
- Open Access
- 19 January 2021
- Published by Elsevier in Journal of Optometry
- Vol. 14 (4) , 342-345
Restitution of potential visual acuity in low vision patients with the use of yoke prisms
- 19 January 2021
- Published by Elsevier in Journal of Optometry
- Vol. 14 (4) , 342-345
Open AccessRestitution of potential visual acuity in low vision patients with the use of yoke prisms
- Open Access
- 1 January 2021
- Published by GN1 Sistemas e Publicacoes Ltd. in Arquivos Brasileiros de Oftalmologia
- Vol. 84 (2) , 179-182
Visual outcomes of audio-luminous biofeedback training for a child with idiopathic nystagmus
To register the scientific output in Ophthalmology, to promote the study, enhancement, and actualization of the professionals of the specialty.
- 1 January 2021
- Published by GN1 Sistemas e Publicacoes Ltd. in Arquivos Brasileiros de Oftalmologia
- Vol. 84 (2) , 179-182
Open AccessVisual outcomes of audio-luminous biofeedback training for a child with idiopathic nystagmus
To register the scientific output in Ophthalmology, to promote the study, enhancement, and actualization of the professionals of the specialty.
- 21 November 2020
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 32 (1) , 296-299
Long term outcomes in dry age-related macular degeneration following low vision rehabilitation interventions
Background: Age-related macular degeneration (AMD) is the leading cause of loss of vision in the older age groups. In the absence of a known therapy, low vision rehabilitation aims at preserving residual functional vision at optimal levels. Long term functional outcomes from Low Vision Rehabilitation (LVR) in AMD cases were never scrutinized in the past. This study brings some clarification in this matter. Methods: This is a retrospective case series study including data up to 2 years following the baseline visit. Low Vision Assessments included microperimetry testing and recommendations for low vision devices for distance vision. Outcomes measures selected for this study were best corrected distance visual acuity, fixation stability and preferred retinal locus (PRL) topography and LVR interventions. Results: Data on 17 patients with an average age of 89.2 ± 4.4 years was collected. In those with better vision than 20/400 loss of vision was about 1.4 letter per year as tested with ETDRS charts compared with losses of four letters per year in a population without LVR interventions. Fixation stability continued to deteriorate while PRL eccentricity seemed to remain the same. In about half of cases there was a change in the topographic location of the PRL to a different retinal quadrant. Conclusion: Long term, as expected, changes were noticed in visual acuity, fixation stability and PRL topography. However, it seems that LVR interventions for distance vision help patients retain significantly better functional vision at the 2 years follow up interval when compared to others.
- 21 November 2020
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 32 (1) , 296-299
Long term outcomes in dry age-related macular degeneration following low vision rehabilitation interventions
Background: Age-related macular degeneration (AMD) is the leading cause of loss of vision in the older age groups. In the absence of a known therapy, low vision rehabilitation aims at preserving residual functional vision at optimal levels. Long term functional outcomes from Low Vision Rehabilitation (LVR) in AMD cases were never scrutinized in the past. This study brings some clarification in this matter. Methods: This is a retrospective case series study including data up to 2 years following the baseline visit. Low Vision Assessments included microperimetry testing and recommendations for low vision devices for distance vision. Outcomes measures selected for this study were best corrected distance visual acuity, fixation stability and preferred retinal locus (PRL) topography and LVR interventions. Results: Data on 17 patients with an average age of 89.2 ± 4.4 years was collected. In those with better vision than 20/400 loss of vision was about 1.4 letter per year as tested with ETDRS charts compared with losses of four letters per year in a population without LVR interventions. Fixation stability continued to deteriorate while PRL eccentricity seemed to remain the same. In about half of cases there was a change in the topographic location of the PRL to a different retinal quadrant. Conclusion: Long term, as expected, changes were noticed in visual acuity, fixation stability and PRL topography. However, it seems that LVR interventions for distance vision help patients retain significantly better functional vision at the 2 years follow up interval when compared to others.